stars 1 stars 2 stars 3

Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with rare diseases.

Gossamer Bio Questions

The Gossamer Bio annual revenue was $28.5 million in 2026.

Faheem Hasnain is the Founder, CEO and Chairman of Gossamer Bio.

117 people are employed at Gossamer Bio.

Gossamer Bio is based in San Diego, California.

The NAICS codes for Gossamer Bio are [42421, 42, 541711, 5417, 541, 54171, 424, 54, 4242].

The SIC codes for Gossamer Bio are [28, 283].

Top Gossamer Bio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users